TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
326,389
|
259,442
|
222,248 |
Financial expenses |
2,102
|
866
|
765 |
Earnings before taxes |
37,902
|
40,264
|
21,277 |
EBITDA |
52,863
|
52,013
|
31,452 |
Total assets |
244,707
|
218,478
|
206,264 |
Current assets |
137,686
|
112,442
|
97,732 |
Current liabilities |
67,757
|
53,338
|
38,673 |
Equity capital |
136,324
|
113,378
|
95,114 |
- share capital |
18,499
|
18,404
|
20,026 |
Employees (average) |
249
|
212
|
184 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
55.7%
|
51.9%
|
46.1% |
Turnover per employee |
1,311
|
1,224
|
1,208 |
Profit as a percentage of turnover |
11.6%
|
15.5%
|
9.6% |
Return on assets (ROA) |
16.3%
|
18.8%
|
10.7% |
Current ratio |
203.2%
|
210.8%
|
252.7% |
Return on equity (ROE) |
27.8%
|
35.5%
|
22.4% |
Change turnover |
65,611
|
55,196
|
-959 |
Change turnover % |
25%
|
27%
|
0% |
Chg. No. of employees |
37
|
28
|
9 |
Chg. No. of employees % |
17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.